Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma
Clinical trial NCT05923879 · UNKNOWN
Trial details
- NCT number
- NCT05923879
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-30
- Primary completion
- 2025-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.